AGNPF (Algernon Pharmaceuticals) Accounts Payable & Accrued Expense : $1.41 Mil (As of May. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Accounts Payable & Accrued Expense?

Algernon Pharmaceuticals's quarterly accounts payable & accrued expense increased from Nov. 2023 ($2.14 Mil) to Feb. 2024 ($2.61 Mil) but then declined from Feb. 2024 ($2.61 Mil) to May. 2024 ($1.41 Mil).

Algernon Pharmaceuticals's annual accounts payable & accrued expense increased from Aug. 2021 ($0.81 Mil) to Aug. 2022 ($1.95 Mil) and increased from Aug. 2022 ($1.95 Mil) to Aug. 2023 ($2.02 Mil).

Algernon Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Algernon Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Accounts Payable & Accrued Expense Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.28

0.46

0.81

1.95

2.02

Algernon Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.79	2.02	2.14	2.61	1.41

Algernon Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Algernon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (OTCPK:AGNPF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.